Free equity investment tool of Japanese companies

HOME >
Company List >
参天製薬+LTT Bio-Pharma (Annual ) >
Financial Statement Details

Financial Statement Details: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: Nippon Shikizai; 日本化学工業; New Japan Chemical; 小野産業; LTT Bio-Pharma; 廣貫堂; Carna Biosciences; KOEI CHEMICAL; ダイトーケミックス; Kawaguchi Chemical Industry

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: 日本アビオニクス

日本アビオニクス

日本アビオニクス

Renesas Electronics

日本セラミック

Financial Statement Details: 参天製薬+LTT Bio-Pharma (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

*Free Download Financial Statement data

F/S Outline: 参天製薬+LTT Bio-Pharma (Annual )

Switch ViewU-Chart U-Chart and F/S F/S

U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Consolidated :Balance sheet (B/S) Consolidated \| Non-Consolidated \| Small \| Large
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	IN(Right half), OUT(Left half), BALANCE(Net Assets)
	* Total: ¥ 199 B * Net: ¥ 165 B (Ratio: 82.71%)	* Total: - * Net: ¥ 802 M
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Cash etc.	¥ 50 B	-
Other Current Assets	¥ 81 B	-
Tangible Assets	¥ 27 B	-
Intangible Assets	¥ 14 B	-
Investment etc.	¥ 25 B	-
Total Assets	¥ 199 B	-
Current Liabilities	¥ 27 B	¥ -802 M
Fixed Liabilities	¥ 7 B	-
Capital stock	¥ 7 B	¥ 100 M
Capital surplus etc.	¥ 158 B	¥ 702 M
Liabilities and net assets	¥ 199 B	-
Consolidated :Income statement (P/L) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	IN(Right half), OUT(Left half), BALANCE(Net Income)
	* Sales: ¥ 119 B * Income: ¥ 16 B (Ratio: 13.87%)	* Sales: ¥ 61 M * Income: ¥ -66 M (Ratio: -107.97%)
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Sales	¥ 119 B	¥ 61 M
Cost of Sales	¥ 41 B	¥ 204 K
Gross profit	¥ 77 B	¥ 61 M
Other income	¥ 1 B	¥ 393 M
SG&A	¥ 52 B	¥ 519 M
Other expenses	¥ 9 B	¥ 1 M
Net income	¥ 16 B	¥ -66 M
Consolidated :Cash flow statement (C/F) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	IN(Right half), OUT(Left half), BALANCE(Net Change in Cash)
	* OCF: ¥ 9 B * Cash: ¥ -15 B	* OCF: ¥ -58 M * Cash: ¥ -50 M
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Operating CF	¥ 9 B	¥ -58 M
Investment CF	¥ -4 B	¥ 7 M
Financial CF	¥ -21 B	-
Foreign Exchange Effects	¥ 972 M	-
Net Change in Cash	¥ -15 B	¥ -50 M
Consolidated :Shareowners' equity (S/S) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	IN(Right half), OUT(Left half), BALANCE(Net Change in Net Assets)
	* Income: ¥ 16 B * Net: ¥ +271 M	* Income: ¥ -66 M * Net: ¥ -64 M
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2012-03-31)
Issuance of new shares	¥ 771 M	-
Dividends from surplus	¥ -8 B	-
Net income	¥ 16 B	¥ -66 M
Purchase of treasury stock	¥ -13 B	-
Other Change in Stockholders Equity	¥ 1 M	-
Other Change in Net Assets	¥ 5 B	¥ 1 M
Net Change in Net Assets	¥ 271 M	¥ -64 M

U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Non-Consolidated :Balance sheet (B/S) Consolidated \| Non-Consolidated \| Small \| Large
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	IN(Right half), OUT(Left half), BALANCE(Net Assets)
	* Total: ¥ 194 B * Net: ¥ 166 B (Ratio: 85.47%)	* Total: ¥ 954 M * Net: ¥ 923 M (Ratio: 96.74%)
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Cash etc.	¥ 42 B	¥ 873 M
Other Current Assets	¥ 74 B	¥ 20 M
Tangible Assets	¥ 22 B	¥ 3 M
Intangible Assets	¥ 1 B	-
Investment etc.	¥ 53 B	¥ 57 M
Total Assets	¥ 194 B	¥ 954 M
Current Liabilities	¥ 24 B	¥ 22 M
Fixed Liabilities	¥ 4 B	¥ 8 M
Capital stock	¥ 7 B	¥ 100 M
Capital surplus etc.	¥ 159 B	¥ 823 M
Liabilities and net assets	¥ 194 B	¥ 954 M
Non-Consolidated :Income statement (P/L) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Sales Cost of Sales Other income SG&A Other expenses Net income	IN(Right half), OUT(Left half), BALANCE(Net Income)
	* Sales: ¥ 106 B * Income: ¥ 17 B (Ratio: 16.60%)	* Sales: ¥ 67 M * Income: ¥ 116 M (Ratio: 172.09%)
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Sales	¥ 106 B	¥ 67 M
Cost of Sales	¥ 38 B	-
Gross profit	¥ 68 B	¥ 67 M
Other income	¥ 896 M	¥ 840 M
SG&A	¥ 42 B	¥ 560 M
Other expenses	¥ 8 B	¥ 231 M
Net income	¥ 17 B	¥ 116 M
Non-Consolidated :Shareowners' equity (S/S) Consolidated \| Non-Consolidated \| Small \| Large
U-Chart	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	IN(Right half), OUT(Left half), BALANCE(Net Change in Net Assets)
	* Income: ¥ 17 B * Net: ¥ -1 B	* Income: ¥ 116 M * Net: ¥ +120 M
Financial Statement Details	参天製薬 (2013-03-31)	LTT Bio-Pharma (2013-03-31)
Issuance of new shares	¥ 771 M	-
Dividends from surplus	¥ -8 B	-
Net income	¥ 17 B	¥ 116 M
Purchase of treasury stock	¥ -13 B	-
Other Change in Stockholders Equity	¥ 1 M	¥ 1 K
Other Change in Net Assets	¥ 1 B	¥ 4 M
Net Change in Net Assets	¥ -1 B	¥ 120 M

Related Information: 参天製薬 LTT Bio-Pharma

Statement Type: Annual : 参天製薬+LTT Bio-Pharma; First quarter : 参天製薬+LTT Bio-Pharma; Second quarter : 参天製薬+LTT Bio-Pharma; Third quarter : 参天製薬+LTT Bio-Pharma

Analysis Menu: Outline : 参天製薬+LTT Bio-Pharma; Statement : 参天製薬+LTT Bio-Pharma; Rating : 参天製薬+LTT Bio-Pharma; Indicator : 参天製薬+LTT Bio-Pharma; Download : 参天製薬+LTT Bio-Pharma

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Osaka - EDIUNET Prefectures; Osaka大阪市 - EDIUNET Prefectures; Tokyo - EDIUNET Prefectures; Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

Ticker	Market	Industry	Month	report	Rating
参天製薬	4536	TSE 1st	Chemicals	3	Annual	BBB
LTT Bio-Pharma	4566	TSE Mothers	Chemicals	3	Annual	C

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

Free equity investment tool of Japanese companies

Financial Statement Details: 参天製薬+LTT Bio-Pharma (Annual )

F/S Outline: 参天製薬+LTT Bio-Pharma (Annual )

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large

Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large

Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large

Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large

Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large

Related Information: 参天製薬 LTT Bio-Pharma

Related company's newest statement

Company Information

Related Company

関連する株式投資情報

EDIUNET Caution